In vitro and in vivo effects of an extract of Ginkgo biloba (EGB 761), Ginkgolide B, and bilobalide on apoptosis in primary cultures of rat hippocampal neurons

Drug Development Research

Volumn 45, Issue 1, 1998, Pages 23-29

  Rapin, Jean R ^a,c   Zaibi, Mohamed ^a   Drieu, Katy ^b  

^a Biochemical Pharmacology   (France)

^b Institut Henri Beaufour   (France)

^c Dospharma   (France)

Author keywords

Antioxidant; Hippocampus; Neurodegeneration; Polynucleosomes; Terpene trilactones

Indexed keywords

BILOBALIDE; GINKGO BILOBA EXTRACT; GINKGOLIDE B;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NONHUMAN; NUCLEOSOME; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; RAT;

EID: 0032411571     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2299(199809)45:1<23::AID-DDR4>3.0.CO;2-0     Document Type: Article

References (14)

1. Barkats M, Venault P, Christen Y, Cohen-Salmon C (1995): Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains. Life Sci 56:213-222.
2. Bauer U (1984): 6-Month double-blind randomized clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneim Forsch Drug Res 34:716-720.
3. Biber A, Chatterjee SS (1995): Pharmacokinetics of ginkgolides A, B and bilobalide after PO administration of Ginkgo biloba extract EGb 761 in the rat. Internal Report, Dr. Willmar Schwabe GmbH & Co., Karlsruhe.
4. Bowling AC, Beal MF (1995): Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 56:1151-1171.
5. Braughler JM, Hall ED (1992): Involvement of lipid peroxidation in CNS injury. J Neurotrauma 9:S1-S7.
6. Bredesen DE (1995): Neural apoptosis. Am Neurol 38:839-851.
7. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, Mee E (1995): In situ evidence for DNA fragmentation in Huntingtons disease striatum and Alzheimer's disease temporal lobes. NeuroReport 6:1053-1057.
8. Drieu K (1986): Préparation et définition de l'extrait de Ginkgo biloba. Presse Méd 15:1455-1457.
9. Dumont E, Petit E, Tarrade T, Nouvelet A (1992): UV-C Irradiation-induced peroxidative degradation of microsomal fatty acids and proteins: Protection by an extract of Ginkgo biloba (EGb 761). Free Radic Biol Med 13:197-203.
10. Haase A, Halama P, Hörr R (1996): Wirksamkeit kurzdauernder Infusionsbehandltingen mit Ginkgo biloba-Spezialextrakt EGb 761 bei Demenz vom vaskulären und Alzheimer-Typ. Z. Gerontol Geriat 29:302-309.
11. Holgado Madruga M, De Castro S, Macias-Nunez JF (1995): Effects of Ginkgo biloba extract on brain aging and oxygen free-radical metabolism in the rat. In Christen Y, Courtois Y, Droy-Lefaix MT (eds): Advances in Ginkgo biloba Extract Research, Vol. 4. Effects of Ginkgo biloba Extract (EGb 761) on Aging and Age-Related Disorders. Paris: Elsevier, pp 71-76.
12. Köse K, Dogan P (1995a): Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 1. Protective effect of Ginkgo biloba extract (EGb 761). Int Med Res 23:1-8.
13. Köse K, Dogan P (1995b): Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants. Int Med Res 23:9-18.
14. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997): A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 278:1327-1332.